Buy Bioblast Pharma Stock | ORPN Stock Price & Latest News | Public.com
ORPN

Bioblast Pharma

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Bioblast Pharma (ORPN) stock trends here

    About ORPN

    Enlivex Therapeutics Ltd. develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions. It produces treatment devices for CAR-T cancer treatment procedures, Graft-versus-Host disease resulting from bone-marrow transplantations...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.08
    -0.17
    -0.25
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.21

    Actual EPS
    Q1 2021

    Stats

    Market Cap$204,87M
    Volume10,14k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$29.40
    1 Year Low$3.59
    Open$13.00
    High$13.22
    Low$13.00

    Buy any stock with any amount of money.

    Download the App
    Download the app